overview

In the ever-evolving field of cardiology, what are best practices when it comes to antiplatelet therapy? Is dual better than monotherapy - and how long should a patient receive therapy after stent implantation? What happens when a patient suddenly appears resistant or non-responsive to therapy? While guidelines provide guidance, do they catch up fast enough when new applicable data are presented and replicated? What is the latest research taking place in this fast-moving environment, and how does that translate to benefits for patients in real-world settings?

These are the issues that impact your practice and will be tackled by a host of renowned experts in the field, led by Dr. Eugene Braunwald, in a lively dinner symposium format that will include active audience participation. The presentations will focus on issues and answers surrounding antiplatelet therapy and where research is taking us in terms of managing our patients. Don't miss this extraordinary opportunity to learn more about this critical area in cardiology.

Join us in Orlando for this complimentary CME Dinner Symposium discussing best practices and critical issues in antiplatelet therapy, including a review of the latest in U.S. and international research. Sponsored by the Annenberg Center for Health Sciences at Eisenhower, and supported by an independent educational grant from Daiichi Sankyo, Inc. and Eli Lilly and Company